Cyto-Barr:

Expert of the Epstein-Barr virus (EBV) and Cytomegalovirus (CMV)

Cyto-Barr is a biotech company located in The Netherlands. Cyto-Barr has expertise, experience and owns patents and materials for applications in diagnostic testing and treatment of diseases, specifically in association with Epstein-Barr virus (EBV) or Cytomegalovirus (CMV).

Cyto-Barr is looking for industrial or NGO partnerships. In these partnerships we focus on a supportive role, we assist in expertise, technology and supply of essential materials. Moreover, a license on our patents will allow our partners to enter market segments in a reliable way.

Today, Cyto-Barr already has more than 40 industrial and several NGO  partners worldwide in diagnostics and therapies for EBV and CMV. Cyto-Barr markers are leading worldwide in the field of EBV routine diagnostics. Cyto-Barr reagents are chemically defined which minimizes production risks and shortens time to market as has been illustrated by numerous FDA approved and CE marked diagnostic tests for EBV developed by our partners.